Ketanest® S 25 mg/ml - Ampullen

DRUG4 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Medical University Of Vienna

Conditions

Complex regional pain syndromeHealthy volunteers - no medical conditionNegative and depressive symptoms in schizophrenia / schizoaffective disordermajor depression

Phase 1

Imaging neural correlates of antidepressant action of ketamine stereoisomers using pharmacological PET/MR imaging and metabolite analysis.

RecruitingCTIS2024-519234-23-00

Medical University Of ViennaHealthy volunteers - no medical condition

Start: 2020-01-17Target: 75Updated: 2025-01-30

Phase 3

A prospective randomized, single blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy

Not yet recruitingCTIS2024-512210-18-00

Medical University Of Viennamajor depression

Target: 100Updated: 2024-07-09

Ketamine for the treatment of depressive and negative symptoms in patients with schizophrenia: a randomized controlled cross-over pilot study.

RecruitingCTIS2024-519097-39-01

Medical University Of ViennaNegative and depressive symptoms in schizophrenia / schizoaffective disorder

Start: 2022-06-23Target: 20Updated: 2025-02-27

Phase 4

Long-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome: a non-inferiority study

Active, not recruitingCTIS2024-511877-31-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Complex regional pain syndrome

Start: 2024-04-22Target: 60Updated: 2024-04-22